BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7967056)

  • 1. [Hereditary spherocytosis associated with non-Hodgkin's lymphoma in the spleen].
    Arisawa K; Morita S; Kojima H; Inui A; Yoshino G; Hayashi Y; Kasuga M
    Rinsho Ketsueki; 1994 Sep; 35(9):871-5. PubMed ID: 7967056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retroperitoneal malignant lymphoma showing follicular type: report of a case].
    Terao T; Fujii Y; Ikeda I; Masuda M; Hirokawa M; Iwabuchi K; Maeda T; Asakura S
    Hinyokika Kiyo; 1992 Oct; 38(10):1151-5. PubMed ID: 1481774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follicular lymphoma in two brothers].
    Asahi A; Okamoto S; Matsushita H; Hattori Y; Takayama N; Ikeda Y
    Rinsho Ketsueki; 2001 May; 42(5):408-13. PubMed ID: 11452461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of primary non-Hodgkin's lymphoma of the vagina with chemotherapy.
    Engin H; Türker A; Abali H; Uner A; Günalp S
    Arch Gynecol Obstet; 2004 Mar; 269(3):208-10. PubMed ID: 12904985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
    López-Guillermo A; García-Conde J; Alvarez-Carmona AM; León P; Maldonado J; Alcalá A; Zubizarreta A; Sancho-Tello R; Carbonell F; Contreras E; Besses C; Hernando A; Fontanillas M; Montserrat E
    Med Clin (Barc); 1998 May; 110(16):601-4. PubMed ID: 9656196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A malignant lymphoma (non-hodgkin lymphoma, follicular type) patient who achieved complete remission by radiochemotherapy].
    Tanaka T; Araki T; Kasuya G; Fujino T; Makita K
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1931-4. PubMed ID: 19920404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study.
    Van Oers MH; Hagenbeek A; Van Glabbeke M; Teodorovic I
    Ann Hematol; 2002 Oct; 81(10):553-7. PubMed ID: 12424535
    [No Abstract]   [Full Text] [Related]  

  • 9. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified CHOP in an aged patient with non-Hodgkin's lymphoma and probable extensive pulmonary involvement.
    Asano Y; Ohshima K; Yoshizawa S; Shiraishi G; Kato K
    Int J Hematol; 1991 Aug; 54(4):327-9. PubMed ID: 1777606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous splenic rupture in a case of non-Hodgkin's lymphoma].
    Dobashi N; Kuraishi Y; Kobayashi T; Hirano A; Isogai Y; Takagi K
    Rinsho Ketsueki; 1993 Feb; 34(2):190-3. PubMed ID: 8492417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
    Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
    Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
    Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
    Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
    J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
    J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
    J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy for follicular lymphoma revisited: not if, but when?
    Lister TA
    J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.